Pharmeca.cz

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Teva Pharmaceuticals CR, s.r.o., against the decision of the State Institute for Drug Control from 8. 1. 2021, under the no. SUKLS275693/2019:

• the appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Laboratori Guidotti SpA, against the decision of the State Institute for Drug Control from 12. 6. 2020, under the no. SUKLS124882/2020:

• the appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Ferring-Léčiva, a.s., against the decision of the State Institute for Drug Control from 23. 1. 2019, under the no. SUKLS201291/2017:

• under article 90 paragraph 4 in connection with article 66 paragraph 2 of the Administrative Code the operative part 5 of the decision under appeal is dismissed and the proceedings are terminated,
• under article 90 paragraph 5 of the Administrative Code the appeal is dismissed and the rest of the decision under appeal is upheld.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Union of health insurance companies, against the decision of the State Institute for Drug Control from 8. 11. 2018, under the no. SUKLS265370/2018:

• the decision under appeal is reversed and the issue is referred back to the State Institute for Drug Control for reappraisal.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Union of health insurance companies, against the decision of the State Institute for Drug Control from 29. 10. 2018, under the no. SUKLS213595/2018:

• the appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Union of health insurance companies, against the decision of the State Institute for Drug Control from 29. 6. 2018, under the no. SUKLS252032/2017:

• the decision under appeal is reversed and the issue is referred back to the State Institute for Drug Control for reappraisal.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Merck Europe B. V., against the decision of the State Institute for Drug Control from 30. 10. 2020, under the no. SUKLS84307/2020:

• the appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Egis Pharmaceuticals PLC, against the decision of the State Institute for Drug Control from 7. 11. 2018, under the no. SUKLS298864/2018:

• the appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz.